The lawsuit covers Pronova BioPharma’s US patent no 7,732,488, US patent no. 7,678,930 and US patent no. 7,718,698.
The patents entitled, ‘Pharmaceutical Composition Comprising Low Concentrations of Environmental Pollutants,’ ‘Process for Decreasing the Amount of Cholesterol in a Marine Oil Using a Volatile Working Fluid,’ and Process for Decreasing Environmental Pollutants in an Oil or a Fat.
Currently, Pronova BioPharma is involved in lawsuits with Teva in connection with the violation of its US patents nos. 5,502,077 ( ‘077 Patent) and 5,656,667 (‘667 Patent) related to Lovaza.